Rational DOE protocols for 96-well plates

Chemometrics and Intelligent Laboratory Systems

Volumn 83, Issue 1, 2006, Pages 66-74

  Olsson, Ing Marie ^a   Johansson, Erik ^b   Berntsson, Martin ^c   Eriksson, Lennart ^b   Gottfries, Johan ^a,d   Wold, Svante ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b Umetrics AB   (Sweden)

^c Umetrics AB   (Sweden)

^d ASTRAZENECA R AND D   (Sweden)

Author keywords

96 well technology; Assay optimisation; DOE; RED MUP

Indexed keywords

ANALYTIC METHOD; ARTICLE; EXPERIMENTAL DESIGN; MATHEMATICAL MODEL; PRIORITY JOURNAL; QUALITY CONTROL; REPORTER GENE; STATISTICAL CONCEPTS;

EID: 33744519380     PISSN: 01697439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemolab.2006.01.005     Document Type: Article

References (18)

1. Box G.E.P., Hunter W.G., and Hunter J.S. Statistics for Experimenters (1978), John Wiley & Sons
2. Manns R.L. Necessity is the mother of invention. The History of Microplates. Business Briefing: Future Drug Discovery (2003)
3. Karlsson L. Development and Optimization of a Simulated Intestinal Fluid for Studies of Enzymatically Mediated Drug Degradation (2004), Göteborgs Universitet, Göteborg
4. Doehlert D.H. Uniform shell designs. Applied Statistics 19 3 (1970) 231-239
5. deAguiar P.F., Bourguignon B., Khots M.S., Massart D.L., and PhanThanLuu R. D-optimal designs. Chemometrics and Intelligent Laboratory Systems 30 2 (1995) 199-210
6. MODDE 7.0, 2003. Umetrics AB, Box 7960, S-90719 Umeå, Sweden.
7. n factorial designs. Technometrics 9 4 (1967) 569-575
8. Plackett R.L., and Burman J.P. The design of optimum multifactorial experiments. Biometrika 33 4 (1946) 305-325
9. Nordfeldt R., Kauppi A.M., Norberg H.A., Wolf-Watz H., and Elofsson M. Small-molecule inhibitors specifically targeting type III secretion. Infection and Immunity 73 5 (2005) 3104-3114
10. Cornelis G.R. Yersinia type III secretion: send in the effectors. The Journal of Cell Biology 158 3 (2002) 401-408
11. Kauppi A.M., Nordfeldt R., Uvell H., Wolf-Watz H., and Elofsson M. Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chemistry and Biology 10 (2003) 241-249
12. Additional information available as supplementary information and at Umetrics Inc. Homepage, www.umetrics.com.
13. Eriksson L., and Johansson E. Multivariate design and modelling in QSAR. Chemometrics and Intelligent Laboratory Systems 34 1 (1996) 1-19
14. Wold S., Josefson M., Gottfries J., and Linusson A. The utility of multivariate design in PLS modeling. Journal of Chemometrics 18 (2004) 156-165
15. Lundstedt T., Seifert E., Abramo L., Thelin B., Nystrom A., Pettersen J., and Bergman R. Experimental design and optimization. Chemometrics and Intelligent Laboratory Systems 42 1-2 (1998) 3-40
16. Lutz M.W., Menius J.A., Choi T.D., Laskody R.G., Domanico P.L., Goetz A.S., and Saussy D.L. Experimental design for high-throughput screening. Drug Discovery Today 1 7 (1996) 277-286
17. Jamieson C., Congreve M.S., Emiabata-Smith D.F., and Ley S.V. A rapid approach for the optimisation of polymer supported reagents in synthesis. Synlett 11 (2000) 1603-1607
18. Svennberg H., Bergh S., and Stenhoff H. Factorial design for the development of automated solid-phase extraction in the 96-well format for determination of tesaglitazar, in plasma, by liquid chromatography-mass spectrometry. Journal of Chromatography B-Analytical Technologies In The Biomedical And Life Sciences 787 2 (2003) 231-241